Vertex Pharmaceuticals Inc (VRTX)
397.43
-0.27
(-0.07%)
USD |
NASDAQ |
Apr 26, 16:00
397.43
0.00 (0.00%)
After-Hours: 18:44
Vertex Pharmaceuticals Net Income (TTM): 3.620B for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 3.620B |
September 30, 2023 | 3.470B |
June 30, 2023 | 3.365B |
March 31, 2023 | 3.260B |
December 31, 2022 | 3.322B |
September 30, 2022 | 3.273B |
June 30, 2022 | 3.195B |
March 31, 2022 | 2.451B |
December 31, 2021 | 2.342B |
September 30, 2021 | 2.176B |
June 30, 2021 | 1.992B |
March 31, 2021 | 2.762B |
December 31, 2020 | 2.712B |
September 30, 2020 | 2.691B |
June 30, 2020 | 2.081B |
March 31, 2020 | 1.511B |
December 31, 2019 | 1.177B |
September 30, 2019 | 2.144B |
June 30, 2019 | 2.215B |
March 31, 2019 | 2.155B |
December 31, 2018 | 2.097B |
September 30, 2018 | 647.05M |
June 30, 2018 | 415.36M |
March 31, 2018 | 225.99M |
December 31, 2017 | 263.48M |
Date | Value |
---|---|
September 30, 2017 | 195.74M |
June 30, 2017 | 259.86M |
March 31, 2017 | 177.34M |
December 31, 2016 | -112.05M |
September 30, 2016 | -218.73M |
June 30, 2016 | -275.04M |
March 31, 2016 | -399.36M |
December 31, 2015 | -556.33M |
September 30, 2015 | -659.26M |
June 30, 2015 | -734.17M |
March 31, 2015 | -704.70M |
December 31, 2014 | -738.56M |
September 30, 2014 | -517.61M |
June 30, 2014 | -471.69M |
March 31, 2014 | -369.47M |
December 31, 2013 | -445.03M |
September 30, 2013 | -565.46M |
June 30, 2013 | -498.87M |
March 31, 2013 | -506.64M |
December 31, 2012 | -107.03M |
September 30, 2012 | 127.74M |
June 30, 2012 | 406.40M |
March 31, 2012 | 297.26M |
December 31, 2011 | 29.57M |
September 30, 2011 | -309.45M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
1.177B
Minimum
Dec 2019
3.620B
Maximum
Dec 2023
2.619B
Average
2.691B
Median
Sep 2020
Net Income (TTM) Benchmarks
Amgen Inc | 6.717B |
Eli Lilly and Co | 5.240B |
Regeneron Pharmaceuticals Inc | 3.954B |
Alpine Immune Sciences Inc | -32.18M |
Moderna Inc | -4.714B |